Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study - Singh, Awadhesh Kumar; Phatak, Sanjeev Ratnakar; Singh, Ritu; Bhattacharjee, Kingshuk; Singh, Nagendra Kumar; Gupta, Arvind; Sharma, Arvind (Vaccine, 2021)
Keywords: Age; Allergy and Immunology; Anti-spike antibody; Antibodies; Antibody Formation; Antibody response; Antigens; Blood groups; Body mass index; Body size; Comorbidities; confidence interval; Confidence intervals; Coronaviruses; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Data collection; Female; females; Firing rate; Health care; Health Personnel; health services; Humans; humoral immunity; Hypertension; Immune response; Immune response (humoral); Immune system; Immunogenicity; India; Infections; Male; males; Manufacturers; Medical personnel; Middle Aged; Proteins; Regression analysis; SARS-CoV-2; seroprevalence; Severe acute respiratory syndrome coronavirus 2; Sex; Side effects; Statistical analysis; Vaccines; India; SARS-CoV-2; Vaccines; Immunogenicity; Comorbidities; Anti-spike antibody